CVE-2026-57913Disclosure

LOWCVSS 7.5 · HIGH

Signal is active with 2 mentions in latest observed window

Immediate actions

Track advisory updates for patch or workaround availability

Recommended action window: Monitor and triage in normal cycle

NVD description

Johnson & Johnson Audit Tracking Management System (ATMS) before 2026-04-21 allows viewing of meeting minutes and transcripts.

Back to dashboard

0.0/ 10 priority

Sources & remediation

Other references

https://eaton-works.com/2026/06/24/jnj-webapp-hacks/

Weakness type (CWE)

CWE-602

Priority

LOW

Exploitation

NONE

PoC

NONE

Patch

NONE

Momentum

NONE

Threat summary

2 mentions across 1 observed day

What's happening

Technical details provided in 2 signals
Disclosure: 2 classified signals
2 total mentions across 1 day

Deep dive

Activity timeline2 mentions / 1d

Signal classification1 categories

Disclosure

2100.0%

Referenced assets2 URLs

By indicator

Full discourse2 posts

Infoflowcloud@infoflowcloud92d
Disclosure
🚨*CVE* CVE-2026-57913 Johnson & Johnson Audit Tracking Management System (ATMS) before 2026-04-21 allows viewing of meeting minutes and transcripts. https://www.cve.org/CVERecord?id=CVE-2026-57913 ----- Traducción: CVE-2026-57913 Johnson & Johnson Audit Tracking Management S… http://infoflow.cloud`
Post summary
The notice announces CVE‑2026‑57913, stating that a version of Johnson & Johnson’s Audit Tracking Management System before 2026‑04‑21 permits unauthorized viewing of meeting minutes and transcripts; no proof of concept, exploit code, or patch information is provided.
0000019
89 followersView on X
CVE@CVEnew92d
Disclosure
CVE-2026-57913 Johnson & Johnson Audit Tracking Management System (ATMS) before 2026-04-21 allows viewing of meeting minutes and transcripts. https://www.cve.org/CVERecord?id=CVE-2026-57913
Post summary
The text announces CVE-2026-57913, noting that Johnson & Johnson's ATMS prior to 2026-04-21 permits unauthorized access to meeting minutes and transcripts.
00000778
57.7K followersView on X

Explore more

Back to dashboard